CEREBRAL ADRENOLEUKODYSTROPHY (CALD)

Clinical trials for CEREBRAL ADRENOLEUKODYSTROPHY (CALD) explained in plain language.

Never miss a new study

Get alerted when new CEREBRAL ADRENOLEUKODYSTROPHY (CALD) trials appear

Sign up with your email to follow new studies for CEREBRAL ADRENOLEUKODYSTROPHY (CALD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Hope for rare brain disease: new drug aims to delay death or paralysis

Disease control Recruiting now

This study tests a drug called leriglitazone in adult men with cerebral adrenoleukodystrophy (cALD), a rare and serious brain disease. The goal is to see if the drug can delay death or the need for permanent breathing support compared to a placebo. About 40 men who cannot or choo…

Matched conditions: CEREBRAL ADRENOLEUKODYSTROPHY (CALD)

Phase: PHASE3 • Sponsor: Minoryx Therapeutics, S.L. • Aim: Disease control

Last updated Apr 25, 2026 20:28 UTC

CEREBRAL ADRENOLEUKODYSTROPHY (CALD)

Get alerted when new CEREBRAL ADRENOLEUKODYSTROPHY (CALD) trials appear

Hope for rare brain disease: new drug aims to delay death or paralysis